November 5, 2025
I.Regulatory and Compliance 1.India Proposes Debarment for Fake Drug Data:New rules allow debarment of manufacturers submitting false information in licensing applications, tightening regulatory oversight.(ID:16924033) 2.Brazil Challenges […]